![](/img/cover-not-exists.png)
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
Chen, J. S., Hsu, C., Chiang, N. J., Tsai, C. S., Tsou, H. H., Huang, S. F., Bai, L. Y., Chang, I. C., Shiah, H. S., Ho, C. L., Yen, C. J., Lee, K. D., Chiu, C. F., Rau, K. M., Yu, M. S., Yang, Y., HsVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv035
Date:
May, 2015
File:
PDF, 228 KB
english, 2015